Interventional News

#InterventionalNews is the international one-stop source news for interventionalists. Subscribe for the latest updates

[Interventional News @IN_publishing]

Texray (@texray_io) has announced that interventional radiologist Ziv Haskal (@ZHaskal; Charlottesville, USA) has joined the company’s clinical and scientific advisory board

@petraapell
https://t.co/X7m5PHB9x3

[Interventional News @IN_publishing]

Interventional radiology has continued to grow as a distinct, clinically oriented specialty, according to a new study published in @JVIRmedia

@saherssabri @SIRspecialists
https://t.co/0gdVIJoRTf

[Interventional News @IN_publishing]

.@IceCureMedical has announced that it has received approval, as a class III medical device, from China’s National Medical Products Administration (NMPA) for its ProSense system and associated cryoprobes

https://t.co/TBj3dOUHQY

[Interventional News @IN_publishing]

Asia-Pacific Society of Cardiovascular and Interventional Radiology (@apscvir) president @TayKiangHiong (Singapore) discusses how the society can support young interventional radiologists and why attending congresses is invaluable for those in training

https://t.co/2eqcsN52GG

[Interventional News @IN_publishing]

EMERALD-3: single tremelimumab regular interval durvalumab (STRIDE) plus lenvatinib plus #TACE provides statistically significant progression free survival improvement versus TACE alone @TheLancet

https://t.co/6Ub02P5an0

[Interventional News @IN_publishing]

.@SIO_Central has today announced that @JohnsHopkins in Baltimore, USA, has been approved to commence enrolment and has subsequently enrolled its first patient in the society’s second clinical trial Tribute

https://t.co/tQnk7JGQF0

[Interventional News @IN_publishing]

.@IceCureMedical today announced that it has entered into an exclusive distribution agreement with Scovas Medical for the distribution of IceCure’s ProSense #cryoablation systems in the Netherlands for breast cancer and #IO

https://t.co/Y1q6auWe3D

[Interventional News @IN_publishing]

Vlasios Sotirchos (New York, USA) discusses how, during #histotripsy's development, adverse events that were not apparent during premarket evaluation have been revealed. Neither unique nor unexpected; this reflects the natural evolution of innovation

https://t.co/bEaigXIcnP

[Interventional News @IN_publishing]

Galvanize Therapeutics (@galvanizetx) has announced the completion of the first commercial procedures using its recently @US_FDA-cleared Aliya EX system

https://t.co/8PYCsQHpAw

[Interventional News @IN_publishing]

Simon Lambracos (@SLambracos; London, UK) puts forward key actions to mitigate emissions in interventional radiology, addressing energy consumption, waste management, supply chain and departmental infrastructure

Read here: https://t.co/i5V6LWCkB6

[Interventional News @IN_publishing]

"I submit that we are the fortu­nate inheritors of a name that is at once accurate and trendy [...] Our adolescent identity crisis has passed" - Read Interventional News' co-editor-in-chief Brian Stainken's latest editorial letter: https://t.co/p4ithbUGlu

[Interventional News @IN_publishing]

Jupiter Endovascular today announced the appointment of interventional cardiologist Catalin Toma as chief medical officer

https://t.co/Mhc5BU6d8P

[Interventional News @IN_publishing]

.@VESALIOcom today announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for pVasc NET, a peripheral mechanical thrombectomy device featuring an integrated distal filter

https://t.co/FKFPfC6VTn

[Interventional News @IN_publishing]

A newly published international survey by @cirsesociety offers a real-world evaluation of intercontinental dispar­ities in #TARE practices between North America and Europe

https://t.co/nUkiZ5Ei4I

[Interventional News @IN_publishing]

.@fastwavemedical has received US Food and Drug Administration (FDA) approval of its investigational device exemption application, which clears the company to begin a US pivotal trial of its Artero electric #IVL system for the treatment of #PAD

https://t.co/uuy6qqR81w

[Interventional News @IN_publishing]

Driven by a passion for both science and art, professor of interventional radiology (IR) Tze Min Wah (@TzeWah1; Leeds, UK) has built a career that combines innovation, technical expertise, and creativity

Read the full interview: https://t.co/VmJtrHIbpH

[Interventional News @IN_publishing]

The ALARA+ Coalition, comprised of nine medical societies, has released a suite of resources to help implement enhanced radiation and occupational safety guidelines for clinicians @saherssabri @SCAI @SIRspecialists @SNISinfo @svinsociety @VascularSVS https://t.co/PeJh9Bb88e

[Interventional News @IN_publishing]

.@cirsesociety has launched the Access to Care initiative, a new programme aimed at improving access to IR treatments and training across sub-Saharan Africa and Eastern and Southeastern Europe https://t.co/WPRgpOrBli

[Interventional News @IN_publishing]

The latest edition of Interventional News is now available to read online!

Our August 2026 edition features coverage from several spring scientific congresses, an exclusive interview with avid researcher and innovator @TzeWah1, and more

https://t.co/fw5l4I3TLf

[Interventional News @IN_publishing]

Gavin Wu and Mina Makary (both Columbus, USA), with Jeffrey Chick and David Shin (both Los Angeles, USA), discuss why higher adverse event severity after-hours/during weekends should be interpreted in the context of patient acuity and procedural urgency

https://t.co/ANv9FUCd8p